Frost & Sullivan Recognizes ResMed for Product Quality Leadership Award in the Sleep Therapy Market

Business Wire, March 16, 2005

SAN FRANCISCO -- Frost & Sullivan today announced ResMed, Inc. (NYSE:RMD) as the recipient of the 2005 Product Quality Leadership of the Year Award for developing the S7 Elite CPAP product line for the sleep therapy market.

Frost & Sullivan presents this Award each year to the company that has demonstrated superior quality control in product manufacturing and more innovation than other companies in the market. ResMed's ability to satisfy customers' needs in terms of user-friendliness and functionality improves the quality of patient care, and promotes customer loyalty.

"Many primary care physicians have voiced their satisfaction with ResMed's S7 Elite CPAP products, as their patients have been reacting favorably to it," says Frost & Sullivan research analyst Alpesh Gandhi. "The S7 Elite CPAP combines integrated humidification, compliance, and efficacy data for both patients and clinicians, as well as several other features that create optimal comfort, convenience, and patient involvement in the therapy."

Patients recommended for nasal continuous positive airway pressure (CPAP) therapy often use the equipment for a lifetime. The device works by sending a constant, continuous, positive airway pressure to keep an open airway for the patient to breathe normally. The S7 Elite CPAP is feature-packed with a heated humidifier that provides patients with thorough humidification the moment the therapy is started, and a patented SmartData diary that enables each patient to track his or her own therapy process. Its lightweight and compact design with high-tech sound baffling system make it eminently portable.

ResMed has thrived upon the quality of its products since it entered the market, and this quality has led ResMed to profound success over the years. Innovation has played a major role in the company's success. Since it was found in 1989, a large number of product advancements and improvements designed to increase patient comfort and encourage compliance with therapy have been developed. Feedback from patients and specialists around the world is used to produce products that meet the different market needs. With greater awareness of the risks of OSA, patients are more likely to turn to therapies such as CPAP, further expanding a market that is experiencing double-digit growth rate globally.

About ResMed, Inc.

ResMed is a leading manufacturer of medical equipment for the screening, treatment, and management of sleep-disordered breathing (SDB), selling a comprehensive range of products in over 60 countries worldwide. ResMed is dedicated to raising awareness among patients and healthcare professionals of the potentially serious health consequences of untreated SDB. ResMed provides quality systems, reliable products, and complete solutions and is dedicated to improving the lives of people suffering from SDB with effective therapy and lasting results.

About Frost & Sullivan

Frost & Sullivan, a global growth consulting company founded in 1961, partners with clients to create value through innovative growth strategies. The foundation of this partnership approach is our Growth Partnership Services platform, whereby we provide industry research, marketing strategies, consulting, and training to our clients to help grow their business. A key benefit that Frost & Sullivan brings to its clients is a global perspective on a broad range of industries, markets, technologies, econometrics, and demographics. With a client list that includes Global 1000 companies, emerging companies, as well as the investment community, Frost & Sullivan has evolved into one of the premier growth consulting companies in the world. For more information, visit www.frost.com.